After the third dose, the T cell response developed in subjects with prior COVID-19 was significantly higher both in the number of S1-specific clones (Figure 1H) and in the amount of IFN-γ secreted per clone (Figure S3I) compared to naïve individuals. The gene discussed is IFNG; the disease is COVID-19.